A pioneering partnership to eliminate hepatitis C

15 Jun 2022
PUU1 - 4A
Supporter session , Collaboration & partnerships

Hepatitis C currently affects an estimated 81,000 people in England. In 2015, this figure was close to 174,000 people.

Through a significant effort of cross-sector partnership, the UK is now well-placed to meet the World Health Organisation’s 2030 goal to reduce HCV-related morbidity and mortality by 65 per cent.

In this session, we explore how partners from the HCV Elimination Programme are working together to eliminate Hep C across the UK. Three years into the Programme we will reflect on progress to date and examine how local health systems are finding innovative ways to reach people often unknowingly living with Hep C.

The discussion will be co-chaired by Dr Dilruwan (Cham) Herath (Executive Medical Affairs Director, MSD UK & Ireland) and Kuldip Sembhi (HCV Elimination Programme Lead, MSD UK) and will feature four speakers with deep expertise in Hep C Elimination: Mark Gillyon-Powell (Head of HCV Elimination Programme, NHS England and Improvement), Carrie Richardson (Northern Regional Manager, Hepatitis C Trust), David Byrne (Cheshire and Merseyside HCV ODN Manager), and Dr Paul Richardson (Clinical Director, Royal Liverpool University Hospital).

This specific session and its agenda has been organised by MSD as part of its overall sponsorship of the NHS ConfedExpo.

Dr Dilruwan (Cham) Herath, Executive Medical Affairs Director - MSD UK & Ireland
Kuldip Sembhi, HCV Elimination Programme Lead - MSD UK
Carrie Richardson, Northern Regional Manager - Hepatitis C Trust
David Byrne, Cheshire and Merseyside HCV ODN Manager - Liverpool University Hospitals NHS Foundation Trust
Dr Paul Richardson, Clinical Director - Liverpool University Hospitals NHS Foundation Trust
Mark Gillyon-Powell, Head of HCV Elimination Programme - NHS England and Improvement